Precision BioSciences Inc (DTIL) — Capital Reinvestment Ratio
Latest as of September 2022:
0.04x
Precision BioSciences Inc (DTIL) has a Capital Reinvestment Ratio of 0.04x as of September 2022, meaning it reinvests 0% of its operating cash flow ($29.19 Million) in capital expenditures ($1.09 Million). See Precision BioSciences Inc (DTIL) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$29.19 Million
USD
Capital Expenditures
$1.09 Million
USD
Data as of
Sep 2022
Most recent filing
Precision BioSciences Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Precision BioSciences Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Precision BioSciences Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Precision BioSciences Inc from 2016 to 2016. For live market cap and broader valuation context, see DTIL market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.02x | $92.27 Million | $2.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow